EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2018-12-30
2017-12-30
2016-12-30
Total Revenue
4,151,600
3,722,800
3,435,300
2,963,700
Cost of Revenue
1,062,900
939,400
875,300
797,400
Gross Profit
3,088,700
2,783,400
2,560,000
2,166,300
Operating Expenses
Research Development
721,900
622,200
552,600
477,800
Selling General and Administrative
1,183,100
1,088,500
984,700
904,700
Total Operating Expenses
1,905,000
1,710,700
1,537,300
1,382,500
Operating Income or Loss
1,183,700
1,072,700
1,022,700
783,800
Interest Expense
-
29,900
23,200
19,200
Total Other Income/Expenses Net
-343,500
-313,400
15,100
-37,500
Income Before Tax
849,200
761,400
1,034,900
737,900
Income Tax Expense
75,500
39,200
451,300
168,400
Income from Continuing Operations
773,700
722,200
583,600
569,500
Net Income
773,700
722,200
583,600
569,500
Net Income available to common shareholders
773,700
722,200
583,600
569,500
Reported EPS
Basic
-
3.45
2.95
2.67
Diluted
-
3.38
2.88
2.61
Weighted average shares outstanding
Basic
-
209,200
210,900
213,000
Diluted
-
213,600
215,900
217,800
EBITDA
-
1,072,700
1,140,000
828,300